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Introduction {#sec1-1}
============

Dementia is one of the largest public health issues, with an estimated 9.9 million new cases worldwide reported in 2015 (Li et al., 2017; Lin, 2018). Dementia is a chronic and progressive clinical syndrome characterized by a decline in memory and other cognitive dysfunctions, which cannot be cured (Chen et al., 2018; White et al., 2018; Maiese, 2019). Cognitive impairment affects people's daily activity and social abilities, and has been reported to have a strong relationship with dementia (Ijaopo, 2017; Das et al., 2019; Manzano Palomo et al., 2019). More than 10% of patients with mild cognitive impairment (MCI) are diagnosed with dementia every year (Wang et al., 2018). It has been reported that more than 10% of people over 65 years old experience MCI, and 15% of these cases progress to dementia every year. Thus, people with MCI are 10 times more likely to develop dementia than healthy people within the same age range (Tervo et al., 2004).

MCI is the transitional stage between normal cognitive function and dementia, and has similar characteristics to the early stage of Alzheimer's disease (Liu et al., 2019; Mondragón et al., 2019). The annual risk of Alzheimer's disease in patients with MCI is as high as 7% to 20% (Petersen et al., 1999). Once cognitive dysfunction occurs, patients are at increased risk of developing dementia (Busse et al., 2006). In the past few decades, many studies have investigated the risk factors for dementia, including neuropsychiatric symptoms (Gunther et al., 2012; Morandi et al., 2012; Forrester et al., 2016; Ismail et al., 2016), hypertension, diabetes, and dyslipidemia (Cherbuin et al., 2009; Solomon et al., 2009; Ott et al., 2010; Tanokashira et al., 2019). However, prevention, detection and intervention of dementia in the early stage are not yet fully understood (Rosato et al., 2019). It is still unclear what prognostic factors affect the outcome of dementia in subjects with cognitive impairment.

Little comprehensive information about the prognosis of MCI on a cohort of people with cognitive impairment has been made available. It is therefore necessary to further verify the risk factors of dementia and explore novel biomarkers that could influence the prognosis of MCI. Therefore, cognitive impairment cohort study was established to investigate the prevalence of MCI, the every-five-year incidence of MCI, and prognostic factors for MCI for the early prevention and preclinical warning of dementia.

Participants and Methods {#sec1-2}
========================

Study design {#sec2-1}
------------

The Jidong cognitive impairment cohort study is a community-based, prospective, long-term observational cohort study to evaluate prognostic factors of cognitive impairment. In this study, all participants were evaluated at baseline and divided into two groups according to Mini-Mental State Examination (MMSE) scores: cognitive impairment group and the normal group (Albanna et al., 2017; Sokołowska et al., 2018). Prognostic risk factors for cognitive impairment were screened by clinicians and well-trained investigators.

Local government attaches great importance to and encourage the participants. This study also received support and cooperation from local participants. Hospitals with participants in physical examination have better medical conditions and convenient transportation, which further facilitates the participation of participants. According to the survey data over five years, the prevalence of hypertension and hyperlipidemia in the cohort study is high, which promotes the development of cardiovascular and cerebrovascular diseases. There are unified physical examination and stable personnel every year, which have enough eligible participants. The two large groups have a unified medical record system, which can query each participant's death, disease and other clinical information. All participants underwent extensive laboratory, clinical, and environmental exposure measurements to identify clinical, biological, and environmental factors associated with MCI. Blood samples were collected at designated physical examination hospitals every year, which had abundant research data.

Ethics statement {#sec2-2}
----------------

The study was performed in accordance with the guideline of the World Medical Association *Declaration of Helsinki* Ethical Principles for Medical Research Involving Human Subjects (2013). Approval was obtained from the Ethics Committee of Kailuan General Hospital of Tangshan City and the Medical Ethics Committee, Staff Hospital, Jidong Oilfield Branch, China National Petroleum Corporation on July 12, 2013 (approval No. 2013 YILUNZI 1). These approvals will be renewed every five years. Written informed consent was obtained from all participants.

Study setting and population {#sec2-3}
----------------------------

From April 2012 to August 2015, participants were recruited via posters in the Physical Examination Department of the Hospital. The basic information including life style and medicine history of participants was reviewed, and we contacted eligible participants. Participants were recruited from Kailuan and Caofeidian communities in Tangshan City, Hebei Province, China. Caofeidian located in the south of Tangshan City, and has a population of 2.687 million. There was no significant difference in baseline between Kaiuan and Caofeidian communities, we found the baseline of Kailuan and Caofeidian community and found that passive smoking had no significant difference in Caofeidian community, and other factors were consistent with the baseline of the Jidong cognitive impairment cohort study. The participants were recruited from Jidong cohort study, which included 12,096 employees and retirees. A sample of 6433 subjects aged 45 years or older was randomly selected, and 5854 subjects voluntarily participated in the study.

### Inclusion criteria {#sec3-1}

The inclusion criteria of the study were as follows: aged ≥ 45 years old, no history of dementia, available questionnaire of cognitive impairment cohort investigation and signed informed consent provided, and blood sample information of the corresponding questionnaire investigation available.

### Exclusion criteria {#sec3-2}

The exclusion criteria of the study were as follows: presence of cerebrovascular diseases, including coronary heart disease, stroke, transient ischemic attack, atrial fibrillation, heart failure, history of any type of cancer, and unavailable questionnaire.

Questionnaire investigation {#sec2-4}
---------------------------

All participants participated in the health information questionnaire with the assistance of a well-trained research assistant. The questionnaire collected information about demographics, lifestyle, and medical history (**[Table 1](#T1){ref-type="table"}**). The demographic information included sex, age, and educational level, which was classified as "illiteracy", "primary school", "junior high school", "high school", or "university and above". Data about lifestyle included a history of smoking, passive smoking, and drinking. The medical history included the history of hypertension, hyperlipidemia, diabetes and cerebrovascular diseases, including stroke and transient ischemic attack, heart failure, atrial fibrillation, and myocardial infarction.

###### 

Physical examination of the Jidong cognitive impairment cohort study

  Test                   Components
  ---------------------- ------------------------------------------------------------------------------------------------------------------------
  Specimen collection    Fasting blood
  Anthropometry          Height, weight, waist and hip circumference
  Participant break      Refreshment break with food provided
  Cardiovascular         Carotid artery sonography, 12-lead electrocardiogram, and vascular profiling (blood pressures and pulse wave velocity)
  Respiratory            Obstructive spirometry
  Skeleton bone          Density examination
  Gynecology (Female)    Gynecologic examination, pap smear, ultrasound, pelvic
  Cognitive impairment   Mini-Mental State Examination
  Dementia               Mini-Mental State Examination, clinical diagnosis

The MMSE {#sec2-5}
--------

MMSE scores were evaluated annually. The MMSE was a global cognitive screening instrument that measures cognitive functions, including orientation, attention, calculation, recall, language processing, and constructional praxis (Albanna et al., 2017; Sokołowska et al., 2018). Cognitive impairment was evaluated using the Chinese version of the MMSE, which had performed well in clinical studies in China (Li et al., 2018; Sun et al., 2019). The MMSE contained 30 questions, each of which is scored as 0 or 1. The total MMSE score thus ranged from 0 to 30 points. Participants with an MMSE score of ≥ 24 were considered as having a normal cognitive function. MMSE scores of 20--23 indicated MCI, MMSE scores of 10--20 indicated moderate cognitive impairment, and \< 10 points indicated dementia (Patel et al., 2003; Gong et al., 2018).

Physical examination {#sec2-6}
--------------------

A physical examination was performed annually. Weight, height, waist circumference, and hip circumference were measured. Blood pressure was determined to the nearest 2 mmHg using a mercury sphygmomanometer. Three systolic blood pressure and diastolic blood pressure readings were collected to calculate the average as the final blood pressure. Blood samples of participants were collected from the antecubital vein in the morning under fasting conditions. They were stored in vacuum tubes containing ethylenediaminetetraacetic acid and coagulation tubes. The hematological tests were conducted on fresh samples at the Central Laboratory of Kailuan General Hospital and Jidong Oil-Field Hospital, China. The fasting blood glucose was measured using the hexokinase/glucose-6-phosphate dehydrogenase method and cholesterol and triglyceride concentrations were determined by enzymatic methods (Mind Bioengineering Co., Ltd., Shanghai, China). The levels of biochemical markers, including cholesterol, blood glucose, triglyceride, insulin, high-density lipoproteins, low-density lipoproteins, alanine aminotransferase, and creatinine, were measured using an auto-analyzer (Hitachi, Tokyo, Japan). Finally, the blood samples were processed and separated on site and stored in a biospecimen bank at --80°C.

Hypertension was defined as a systolic blood pressure ≥ 140 mmHg or a diastolic blood pressure ≥ 90 mmHg. Diabetes was defined as a fasting glucose concentration ≥ 1260 mg/L or a non-fasting glucose concentration ≥ 1998 mg/L. Dyslipidemia was defined as a serum triglyceride ≥ 1500 mg/L, low-density lipoprotein cholesterol ≥ 1300 mg/L, or high-density lipoprotein cholesterol ≤ 400 mg/L. Any use of current medication or self-reported disease history was also used for the medical diagnoses.

Assessment of carotid artery stenosis {#sec2-7}
-------------------------------------

All participants underwent a bilateral carotid duplex ultrasound (EME Companion, Nicolet, Madison, WI, USA), which is the standard diagnostic examination for carotid stenosis. Participants with carotid stenosis (\> 50%) were graded into the following strata according to the recommendations of radiologists and the results: 50--69% stenosis, ≥ 70% stenosis but less than near occlusion (Grant et al., 2003). The participants with severe carotid artery stenosis were advised to undergo further examinations such as CT, MRI, and angiography examinations. The bilateral carotid duplex ultrasound was evaluated annually.

Assessment of follow-up and outcomes {#sec2-8}
------------------------------------

### Procedure of follow-up {#sec3-3}

The duration of the follow-up will be 10 years and the study participants will be followed up via face-to-face interviews once every year in a routine medical examination until December 31, 2024, or until the occurrence of an outcome event as defined in this study. Interviewers will continue to collect data on cognitive impairment, demography, lifestyle, history of disease and basic physical symptoms, blood samples, anthropometry, dementia, and occurrence of other diseases such as cardiovascular diseases. Questionnaires were collected by trained researchers. Physical and clinical examinations were carried out by designated hospital professionals. Questionnaires and clinical physical examinations will be performed according to the same criteria as the baseline survey. Data on clinical outcomes will be extracted using a standard operational procedure follow-up system, including hospitalization reports and files from local general practitioners and medical specialists. The following data on chronic diseases will also be collected: hypertension, hyperlipidemia, diabetes, ischemic stroke, other neurodegenerative diseases, suboptimal health, chronic hepatitis, chronic kidney disease, and cancer.

### Measures and outcomes {#sec3-4}

The primary outcome of this prospective observational cohort study was dementia, including senile dementia, vascular dementia, mixed dementia, and other types of dementia during a 10-year follow up. The every-five-year incidence of cognitive impairment will be recorded. Dementia will be diagnosed according to the criteria of the American Psychiatric Association's *Diagnostic and Statistical Manual of Mental Disorders*, fourth edition (American Psychiatric Association (1994) DSM-IV Criteria) and the International Working Group (Winblad et al., 2004) criteria. All dementia records will be reviewed by certified neurologists and neuropsychologists. If no consensus on diagnosis is reached, the third higher-level expert will review the unclear diagnosis. The final diagnosis will be based on the clinical judgment of the consensus group.

The secondary outcome was the decline in quality of life during the 10-year follow up. The decline in quality of life was assessed using Quality of Life (QoL). QoL developed through beliefs, experiences, and expectations, which were subjective phenomena (Bubien et al., 1996; Testa et al., 1996). QoL included multiple dimensions such as individual perception, experiences, beliefs and expectations (Reynolds et al., 2008).

The MMSE score is used to assess cognitive functioning and the occurrence of relevant diseases. The MMSE score is influenced by age and years of education; participants with higher educational levels perform better than those with lower levels, and cognitive abilities decline with age (Carpinelli Mazzi et al., 2019), which leads to a decline in quality of life.

Quality control {#sec2-9}
---------------

All investigators and clinicians were trained in all items including the questionnaires and all aspects of measurements about laboratory, clinical, and environmental exposure measurements (using standardized techniques). Training was conducted within the laboratories of each participating investigator under the supervision of experienced staff, until the required standard of testing and competency was achieved. During the follow-up, all items will not only be randomly sampled, but also regularly monitored centrally to assess the quality of items, the time delay of blood processing, and the accuracy of data. In addition, the staff of the third party (Rehabilitation Medical Technology Development Company) will also monitor the quality control of the follow-up work.

Statistical analysis {#sec2-10}
--------------------

All the data were examined to ensure the accuracy of data and analyzed using SAS software (version 9.1; SAS Institute, Cary, NC, USA). First, descriptive statistical methods were used to reveal the distribution of baseline characteristics, including demographic variables, lifestyle, cognitive function, and risk factors. Continuous variables are expressed as the mean ± SD. Categorical variables are expressed as counts (percentages). Second, chi-square tests were used to compare categorical variables between groups. The significance level (two-sided) was α = 0.05. Changes from baseline to yearly follow-up in prognosis risk factors of cognitive impairment, sociodemographic factors, and dementia was measured. Relationships between variables of interest will be investigated using relevant statistical models. We will apply survival analysis, logistic regression, linear regression to measure the changes from baseline to yearly follow-up in risk factors, the primary or secondary outcomes, and sociodemographic factors. These analyses will focus on the factors that influence cognitive decline and the incidence of dementia.

Results {#sec1-3}
=======

Based on the inclusion and exclusion criteria, 5854 participants were included into Jidong cognitive impairment cohort study (**[Figure 1](#F1){ref-type="fig"}**). The mean age of the participants was 57.4 ± 9.5 years and 55.1% of participants were male. Baseline characteristics of participants are summarized in **[Table 2](#T2){ref-type="table"}**. Among the study population, 39.2% of the participants completed junior high school, 67.0% never smoked, and 69.4% never drank alcohol.

![Flow chart of the Jidong cognitive impairment cohort study.](NRR-15-1111-g002){#F1}

###### 

Baseline characteristics of participants in Jidong cognitive impairment cohort study

  Characteristics                                  Total         Male          Female        *P*\*
  ------------------------------------------------ ------------- ------------- ------------- ----------
  *n*                                              5854          3223          2631          
  Age (yr)                                         57.4±9.5      58.4±10.1     56.1±8.6      \< 0.001
  Education                                                                                  \< 0.001
   Illiteracy                                      509 (8.7)     236 (7.3)     273 (10.4)    
   Primary school                                  664 (11.3)    364 (11.3)    300 (11.4)    
   Junior high school                              2297 (39.2)   1348 (41.8)   949 (36.1)    
   High school                                     1221 (20.9)   579 (18.0)    642 (24.4)    
   University and above                            1163 (19.8)   696 (21.6)    467 (17.8)    
  Previous history of disease                                                                
   Arterial hypertension                           603 (10.3)    419 (13.0)    184 (7.0)     \< 0.001
   Diabetes                                        175 (3.0)     106 (3.2)     69 (2.6)      0.136
   Dyslipidemia                                    435 (7.4)     258 (8.0)     177 (6.7)     0.064
  Smoking                                                                                    \< 0.001
   Never                                           3923 (67.0)   1391 (43.1)   2532 (96.2)   
   Current                                         1598 (27.3)   1508 (46.8)   90 (3.4)      
   Former (quit smoking for less than 12 months)   91 (1.6)      87(2.7)       4 (0.2)       
   Former (quit smoking for more than 12 months)   242 (4.1)     237 (7.4)     5 (0.2)       
   Passive smoking                                 1158 (19.8)   540 (16.8)    618 (23.5)    \< 0.001
  Alcohol consumption                                                                        \< 0.001
   Never                                           4065 (69.4)   1570 (48.7)   2495 (94.8)   
   Less than two standard drinks                   1211 (20.7)   1099 (34.1)   112 (4.3)     
   Equal or more than two standard drinks          472 (8.1)     463 (14.4)    9 (0.3)       
   Drinking, but not quantities                    106 (1.8)     91 (2.8)      15 (0.6)      

Data are expressed as the *n* (%). \*The results were analyzed by the chi-square test. For ranked data, Wilcoxon rank sum test was used for two groups of data and Kruskal-Wallis test was used for multiple groups of data.

**[Table 3](#T3){ref-type="table"}** shows the distributions of factors about cognitive impairment among participants with or without cognitive impairment. The prevalence of MCI in the study population was 5.5%. The age, educational level, drinking, passive smoking, and blood pressure differed significantly between the cognitive impairment and normal groups (*P* \< 0.05). The prevalence of cognitive impairment significantly increased with age. Participants with a lower educational level had a higher prevalence of cognitive impairment. There were no significant between-group differences in sex, diabetes mellitus, dyslipidemia, or smoking.

###### 

Factor distribution in participants with or without cognitive impairment

  Characteristics                                  Total   Cognitive impairment   Non-cognitive impairment   *P*\*
  ------------------------------------------------ ------- ---------------------- -------------------------- ----------
  *n*                                              5854    320                    5534                       
  Age (yr)                                                                                                   \< 0.001
   45--55                                          2641    60 (2.3)               2581 (97.7)                
   55--65                                          2025    117 (5.8)              1908 (94.2)                
   65--75                                          817     67 (8.2)               750 (91.8)                 
   \> 75                                           371     76 (20.5)              295 (79.5)                 
  Sex                                                                                                        0.196
   Male                                            3223    165 (5.1)              3058 (94.9)                
   Female                                          2631    155 (5.9)              2476 (94.1)                
  Education                                                                                                  \< 0.001
   Illiteracy                                      273     98 (35.9)              175 (64.1)                 
   Primary school                                  324     55 (17.0)              269 (83.0)                 
   Junior high school                              2397    134 (5.6)              2263 (94.4)                
    High school                                    1521    23 (1.5)               1498 (98.5)                
   University and above                            1339    10 (0.7)               1329 (99.3)                
  Previous history of disease                                                                                
   Arterial hypertension                           603     50 (8.3)               553 (91.7)                 0.001
   Diabetes mellitus                               175     15 (8.6)               160 (91.4)                 0.067
   Dyslipidemia                                    435     27 (6.2)               408 (93.8)                 0.480
  Smoking                                                                                                    0.077
   Never                                           3923    222 (5.7)              3701 (94.3)                
   Current                                         1598    73 (4.6)               1525 (95.4)                
   Former (quit smoking for less than 12 months)   91      9 (9.9)                82 (90.1)                  
   Former (quit smoking for more than 12 months)   242     16 (6.6)               226 (93.4)                 
   Passive smoking                                 1122    41 (3.7)               1081 (96.3)                \< 0.001
  Alcohol consumption                                                                                        \< 0.001
   Never                                           4065    249 (6.1)              3816 (93.9)                
   Less than two standard drinks                   1211    46 (3.8)               1165 (96.2)                
   Equal or more than two standard drinks          472     22 (4.7)               450 (95.3)                 
   Drinking, but not quantities                    106     3 (2.8)                103 (97.2)                 

Data are expressed as the *n* (%). \*The results were analyzed by the chi-square test. For ranked data, Wilcoxon rank sum test was used for two groups of data and Kruskal-Wallis test was used for multiple groups of data.

The multivariate logistic regression model showed that age (OR = 1.059, 95% CI = 1.044--1.074) and arterial hypertension (OR = 1.665, 95% CI = 1.143--2.427) were risk factors for MCI. Taking the 'illiteracy' educational level as a reference, odds ratio values of primary school (OR = 0.425, 95% CI = 0.254--0.711), junior middle school (OR = 0.152, 95% CI = 0.096--0.241), high school (OR = 0.057, 95% CI = 0.032--0.103), university and above (OR = 0.029, 95% CI = 0.014--0.062) reduced significantly, which indicates that with the increase in educational level, cognitive impairment gradually decreased (OR \< 1, *P* \< 0.05) (**[Table 4](#T4){ref-type="table"}**).

###### 

Relationship between cognitive impairment and risk factors

  Variable                                  β         SE      *Wald*   *P*        OR          95% CI
  ----------------------------------------- --------- ------- -------- ---------- ----------- --------------
  Age\*                                     0.057     0.007   63.764   \< 0.001   1.059       1.044--1.074
  Educational level\*                                                                         
   Illiteracy                                                                     Reference   
   Primary school                           --0.856   0.263   10.614   0.0011     0.425       0.254--0.711
   Junior high school                       --1.886   0.235   64.317   \< 0.001   0.152       0.096--0.241
   High school                              --2.863   0.302   89.747   \< 0.001   0.057       0.032--0.103
   University and above                     --3.531   0.386   83.616   \< 0.001   0.029       0.014--0.062
  Arterial hypertension\*                   0.51      0.192   7.052    0.008      1.665       1.143--2.427
  Passive smoking\*                         0.089     0.192   0.212    0.645      1.093       0.750--1.593
  Alcohol consumption\*                                                                       
   Never                                                                          Reference   
   Less than two standard drinks            --0.513   0.187   7.525    0.006      0.599       0.415--0.864
   Equal or more than two standard drinks   0.505     0.276   3.33     0.068      1.656       0.963--2.847
   Drinking, but not quantities             0.099     0.459   0.047    0.828      1.105       0.449--2.717

\*: Screening out meaningful single-factor indicators (*P* \< 0.05). SE: Standard error; Wald: chi-square value; OR: odds ratio; CI: confidence interval.

Discussion {#sec1-4}
==========

In 2012, the World Health Organization reported that dementia had become global public health issues (Cahill S, 2019). In China, approximately 30% of subjects over the age of 80 years suffer from dementia (Rocca et al., 1991; White et al., 1996). The previous population-based studies examined the rate of conversion of dementia among persons with MCI, and the rate of conversion from MCI to dementia was much higher than the normal cognitive population (Bozoki et al., 2001; Morris et al., 2001). Bennett et al. (2002) followed up 211 patients with MCI for 4--5 years and found that the rate of conversion from MCI to Alzheimer's disease was 7.5% every year, which was 3.1 times higher than the normal cognitive population. Petersen et al. (1999) found that the rate of conversion from MCI to Alzheimer's disease (10--12% every year) was 10 times higher than the normal cognitive population. Owing to methodological differences including different definitions and different scales, the annual conversion rates of dementia varied from 10% to 20% (Petersen et al., 2001). Little research has been conducted in China. Because the living habits and environment of people in each region will have different impact, it is of great significance to investigate cognitive impairment in China. The Jidong cognitive impairment cohort study is an exclusive cohort of patients with cognitive impairment in China. This study will attempt to explore the risk factors of MCI transition to Alzheimer's disease for the early prevention of dementia.

At baseline, we found that age, drinking, passive smoking, and blood pressure were significantly associated with cognitive impairment. Women had a higher MCI rate than men, which indicates that women have a higher risk of developing dementia, whereas the differences in smoking, diabetes, and hyperlipidemia were not significant between the cognitive impairment and normal groups. The multivariate logistic regression models revealed that age and arterial hypertension were risk factors for MCI. With an increase in educational level, cognitive impairment decreased gradually. However, the participants in this study tended to be younger. In patients with cognitive impairment, there was no significant difference between patients with diabetes and hyperlipidemia in our study, because the awareness of illness in diabetes and hyperlipidemia patients is low. This study was not found the correlation between smoking and cognitive impairment, which needs to be further validated by a follow up. Previous work has found that cognitive impairment is significantly correlated with stroke and coronary heart disease (Lu et al., 2016; Petrova et al., 2018). Ballard et al. (2003) found that more than 30% of patients with stroke developed cognitive impairment within 3--15 months, and 9% of them developed dementia.

After years of follow-up, further longitudinal studies will provide evidence to reveal the prognostic factors of MCI. The Jidong cognitive impairment cohort study will characterize cognitive impairment and accurately estimate the incidence of dementia. This study contributes to the comprehensive assessment of objective health conditions as well as lifestyle and environmental factors. Our results support some previous studies reporting an association of age and hypertension with heart disease and cognitive impairment (Tervo et al., 2004; Iadecola et al., 2016; Stewart et al., 2019). Aging and hypertension were significant and independent risk factors for the conversion to MCI. MCI is associated with cardiovascular risk factors and contributes to the development of cardiovascular diseases (Cherbuin et al., 2009; Solomon et al., 2009). In contrast, a higher level of education was a protective factor for the conversion to dementia. A lower educational level was associated with higher chances of cognitive impairment. However, the blood samples were not measured at baseline, but we have collected them annually since 2015.

Compared with other cognitive impairment cohorts, the design and study population of these studies are presented in **[Table 5](#T5){ref-type="table"}** (Vannier-Nitenberg et al., 2013; van Rijsbergen et al., 2013; Arntz et al., 2014; Palmer et al., 2015; van Rooij et al., 2015; Mauthner et al., 2016; Hooghiemstra et al., 2017; Soares et al., 2017; Aben et al., 2018; Song et al., 2019). Compared with previous studies, the sample size of the present study is larger, and the follow-up time will be longer. The middle-aged and elderly people over 45 years of age were selected, which is conducive to the continuation of follow-up. In this study, the diagnostic tool was the MMSE scale. From the **[Table 5](#T5){ref-type="table"}**, we can see that each study used different diagnostic tools. The MMSE scale can be used as a direct diagnostic tool. Some studies have also combined other scales to diagnose dementia, such as the Rey Auditory Language Learning Test and the Cognitive Failure Questionnaire. Furthermore, the diagnostic criteria between these different tools are different. According to the MMSE score, some studies consider the healthy group to be those with an MMSE score \> 26, while in this study, the healthy group was considered to be those with an MMSE score ≥ 24. The outcome was also different between studies, and included dementia, stroke, cardiovascular events, and cognitive impairment. In addition, the diagnostic tools in this study need to be further improved, and the combination of other diagnostic tools can better assess cognitive impairment. During the follow-up in 2019, we used a combination of MMSE and Montreal Cognitive Assessment (MoCA).

###### 

General characteristics of studies on cognitive impairment cohort study

  Author                            Sample size (*n*)   Age (yr)        Diagnostic tools                                                                     Outcome                                  Follow-up          Cohort location
  --------------------------------- ------------------- --------------- ------------------------------------------------------------------------------------ ---------------------------------------- ------------------ -----------------
  van Rijsbergen et al. (2013)      300                 Over 18         Cognitive failures questionnaire                                                     Stroke                                   2009/2014          Netherlands
  Vannier-Nitenberg et al. (2013)   620                 Over 65         MMSE                                                                                 Mild cognitive impairment and dementia   2009/2013          France
  Arntz et al. (2014)               1500                18--49          Wechsler adult intelligence scale - fourth edition/Cognitive failure questionnaire   Death                                                       USA
  Palmer et al. (2015)              750                 Over 18         MMSE/Rey auditory verbal learning test                                               Cardiovascular events                    2013-07/ 2014-04   Italy
  van Rooij et al. (2015)           150                 Over 45         Cognitive failures questionnaire                                                     Cognitive impairment                                        Netherlands
  Mauthner et al. (2016)            250                 Over 20         Montreal cognitive assessment                                                        Cognitive impairment                     2015-01/ 2020-06   Swiss
  Hooghiemstra et al. (2017)        645                 Over 50         MMSE                                                                                 Vascular cognitive impairment            2014/2019          Dutch
  Soares et al. (2017)              1125                Over 60 years   MMSE                                                                                 Cognitive impairment                     2004/2011          Brazil
  Aben et al. (2018)                350                 Over 50         Montreal cognitive assessment                                                        Cognitive recovery                       2017-01/ 2019-06   Netherlands
  Song et al. (2019)                5854                Over 45         MMSE                                                                                 Dementia                                 2015/2024          China

MMSE: Mini-Mental State Examination.

Previous work has also reported some diseases to be associated with cognitive impairment, including Alzheimer's disease, delirium, neurocognitive impairment, renal hemodialysis, acute ischemic stroke, transient cerebral ischemia, and type 2 diabetes. The advantages of our study are as follows: (1) we recruited participants over 45 years or older as study population. This could help to screen for cognitive impairment from an earlier time point. (2) Bilateral carotid duplex ultrasound was used to detect the degree of carotid artery stenosis. (3) Our questionnaires were administered face to face after investigators had received strict training, and follow-up surveys will be conducted every year. (4) We will collect blood samples every year to investigated the biomarkers associated with dementia.

The present study has some limitations. First, examinations of cognitive impairment should be carried out in the field involving cognition comprehensively such as orientation, recall, attention, calculation, language processing and constructional praxis. Different neuropsychological scales should be used to assess cognition. Additionally, the study sample was from Kailuan and Caofeidian communities, Tangshan city, in northern China, which might not represent the entire Chinese population. Moreover, the questionnaire might lead to recall bias. Nevertheless, we can reduce the recall bias by comparing and analyzing the results of the baseline survey and clinical examination.

This report elaborated the theoretical objectives, design, and baseline characteristics of Jidong cognitive impairment cohort study. This study was aimed to survey the baseline of Jidong cognitive impairment cohort study, especially the associations between prognostic factors of cognitive impairment and dementia in China, which was expected to provide evidence for the intervention of dementia in the future.
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